CEMIP and colorectal carcinoma: In particular, we identified NKD2, FOXQ1, and CEMIP as CTNB1-regulated genes, and the expression levels of these genes may be used as surrogate markers for indicating the activated Wnt/beta-catenin pathway in CRC tissues.